IDORSIA N/ CH0363463438 /
2024-03-28 5:30:28 PM | Chg. +0.2560 | Volume | Bid9:52:35 PM | Ask9:52:35 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
2.8280CHF | +9.95% | 1.87 mill. Turnover: 5.27 mill. |
-Bid Size: 3,000 | 2.8800Ask Size: 1,000 | -CHF | - | - |
GlobeNewswire
03-27
Sosei Heptares Confirms Re-election of its Board and Executive Management Team and the Approval of C...
GlobeNewswire
02-28
Idorsia and Viatris enter into a significant global research and development collaboration
GlobeNewswire
02-16
Sosei Group: Notice of Change of Corporate Name to Nxera Pharma and Change of Location of Head Offic...
GlobeNewswire
02-13
Sosei Heptares Operational Highlights and Consolidated Results for 12 Months ended 31 December 2023
GlobeNewswire
01-05
Sosei Group Announces Appointment of Experienced Pharmaceutical Executive Toshihiro Maeda as Chief O...
GlobeNewswire
2023-12-07
Sosei Group Announces Marketing Approval for PIVLAZ™ (clazosentan sodium) 150 mg in South Korea
GlobeNewswire
2023-11-15
Pharvaris Appoints Stefan Abele, Ph.D., as Chief Technical Operations Officer
GlobeNewswire
2023-11-10
Sosei Heptares Operational Highlights and Consolidated Results for the Third Quarter and First Nine ...
GlobeNewswire
2023-11-03
New Phase 3 data with aprocitentan for patients with resistant hypertension has been presented at th...
GlobeNewswire
2023-10-31
Sosei Heptares Announces Submission of New Drug Application in Japan for Daridorexant (ACT-541468), ...
GlobeNewswire
2023-10-25
Sosei Heptares to Host R&D Day Highlighting its Innovative R&D and Late-Stage Development Progress
GlobeNewswire
2023-09-11
Oculis Expands its Executive Leadership Team and Appoints Rebecca Weil, Ph.D. as Chief Commercial Of...
GlobeNewswire
2022-02-17
Antares Pharma To Report Fourth Quarter And Full-Year 2021 Financial And Operating Results
GlobeNewswire
2022-02-08
Idorsia announces financial results for 2021 – 2022 to be a transformative year – Sustainable profit...
GlobeNewswire
2022-02-03
Nox Health Announces New Chief Marketing Officer, SVP of Content and VP of Security
GlobeNewswire
2022-01-26
Idorsia expands its commercialization partnership with Syneos Health for daridorexant in Europe and ...
GlobeNewswire
2022-01-18
Antares Pharma Receives FDA Fast Track Designation for ATRS-1902 for Adrenal Crisis Rescue
GlobeNewswire
2022-01-11
Antares Pharma Announces Positive Results From Phase I Study For ATRS-1902 For Adrenal Crisis Rescue
GlobeNewswire
2022-01-10
Idorsia presents at the 40th J.P. Morgan Healthcare Conference – Ready for first product launches – ...